Voyager Therapeutics

Last updated: August 02, 2024

Steven Paul, Founder
Steven Paul, Founder
USA | Funding: $374M (+)

Website: http://www.voyagertherapeutics.com/

Voyager Therapeutics is a clinical stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS). Gene therapy has the potential to transform the treatment of CNS and other diseases by providing a one-time therapy that dramatically improves patients' lives.